Concurrent parC and gyrA fluoroquinolone resistance mutations and associated strains in Mycoplasma genitalium in Queensland, Australia

J Antimicrob Chemother. 2024 Feb 1;79(2):467-469. doi: 10.1093/jac/dkad373.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Australia / epidemiology
  • Bacterial Proteins* / genetics
  • Bacterial Proteins* / metabolism
  • DNA Gyrase* / genetics
  • DNA Gyrase* / metabolism
  • Drug Resistance, Bacterial*
  • Fluoroquinolones / pharmacology
  • Humans
  • Macrolides
  • Mutation
  • Mycoplasma Infections* / drug therapy
  • Mycoplasma Infections* / epidemiology
  • Mycoplasma Infections* / microbiology
  • Mycoplasma genitalium* / genetics
  • Queensland

Substances

  • Anti-Bacterial Agents
  • Fluoroquinolones
  • Macrolides
  • DNA Gyrase
  • Bacterial Proteins